UCB Farchim SA v Cipla Ltd (2010)
High Court of Delhi·8 February 2010
Latest update: . Case: Hanmi Pharm Co Ltd v Controller General of Patents and Designs. Doctrine: Amendment Before the Controller.
Is pre-grant opposition under section 25(1) an adversarial proceeding between the opponent and the applicant?
A representation under section 25(1) is in aid of the power of examination, and it would be incorrect to characterise the proceedings at that stage to be adversarial.
Doctrine last updated on 12 November 2026
The Nature of Pre-grant Opposition, Ali on Patents, www.aop.onl/pre-grant-nature
1Pre-grant opposition, though initiated by a third party, will be regarded as an extension of the application procedure as the opposition takes place before the grant of the application. For this reason, pre-grant opposition will be treated as a proceeding involving the Controller and the applicant. The role of the opponent is merely to supply grounds of opposition and the material to support the grounds. The Patent Act and the Patent Rules indicate that the opponent is not a proper and necessary party to the opposition proceedings. In fact, the power of the controller to revoke and amend an application conferred under s 15 may be exercised even without a pre-grant opposition. The opponent only presents information to the Controller in aiding him to decide the application in the light of the information presented. The outcome of the application can be the same even without an opposition, if the Controller exercises the powers vested in him in deciding an application.
2A comparison between the procedures of pre-grant and post-grant opposition will give an unmistakable impression that the pre-grant opposition proceedings are not intended to be a proceeding between parties, an inter partes proceeding, but is only designed as an aid to the examination process. The representation made by the opponent in pre-grant opposition will not become a part of the proceedings upon the fact of it being made before the Controller. The opposition is entertained only if the Controller is satisfied that a prima facie case is made out in the representation. (Patent Rules 2003, r 55(3).) Hence, the applicant will be informed about the opposition only if the Controller, in his opinion, is satisfied about the merits of the opposition. A pre-grant opposition is conducted as a part of the application stage and the proceedings are between the Controller and the applicant. In contrast, the filing of notice of opposition gives the opponent the right to initiate the opposition proceedings and a copy of the same will be served on the patentee regardless of its merit or the opinion of the Controller about the same. (Patent Rules 2003, r 57.) Most of the cases discussed below interpreted r 55 as it existed before the 2016 and 2024 amendments. The said amendments have significantly changed the procedure of pre-grant opposition, which now resembles post-grant opposition more closely than it did before the amendment.
3In UCB Farchim v Cipla (2010) the Delhi High Court, in a case decided before r 55 was amended by the changes made in 2016 and 2024, held that “In the first instance a distinction has to be drawn between a pre-grant opposition and a post-grant opposition.” “A second significant difference, after the amendment of 2005, is that a pre-grant opposition can be filed by ‘any person’ whereas a post-grant opposition under Section 25(2) can be filed only by ‘any person interested’.” “A third significant difference is that the representation at the stage of pre-grant is considered by the Controller himself.” “This Court finds merit in the contention that the pre-grant opposition is in fact ‘in aid of the examination’ of the patent application by the Controller.” (para 13)
4In UCB Farchim the Delhi High Court held that for opposers who “are persons” interested “within the meaning of Section 25(2) and Section 64 of the Patents Act, their remedy against the rejection of their pre-grant opposition is to file a post-grant opposition under Section 25(2) and await the decision of the Controller.” (para 18) It held that “the legislature appears to have consciously denied to a third party a further statutory remedy of a post-grant opposition in the event of such third party not succeeding in the pre-grant stage to prevent the grant of patent” (para 20), and that “where a pre-grant opposition under Section 25 (1) is filed by a person who is a third party and not a person interested in the sense of the term under Section 25(2) or Section 64 of the Patents Act, and such pre-grant opposition is rejected by the Controller, it would be for this Court when approached by such third party pre-grant opposer under Article 226 of the Constitution to determine if in the facts and circumstances, the petition requires to be entertained.” (para 21)
5In Neon Laboratories v Troikaa Pharma (2010) the Division Bench of the Bombay High Court reproduced the holding of the Division Bench of the Madras High Court that “the pre-grant opposition proceedings come within the sweep of ‘any proceedings’ under Section 77 of the said Act” and that the Controller “is thus having the trappings of a Civil Court. Proceeding before such an authority are obviously a quasi-judicial proceedings.” (para 36) The Bench held that “the interpretation placed by the Division Bench of Madras High Court, in the context of identical submissions and on the same statutory provisions, cannot be brushed-aside” and that “The nature of the proceedings, right of hearing conferred and importantly the lis between the parties, has to be borne in mind” (para 39).
6The difference between the two oppositions was stated by the Supreme Court two years before UCB Farchim, in J. Mitra v Assistant Controller of Patents & Designs (2008), “The ground of challenge under Section 25(1) is identical to Section 25(2) of the said 1970 Act. However, Section 25(1) is wider than Section 25(2) as the latter is available only to a ‘person aggrieved’. The main difference between Section 25(1) and Section 25(2), as brought about by Patents (Amendment) Act, 2005, is that even after a patent is granted, ‘post-grant opposition’ can be filed under Section 25 (2) for a period of one year.” (para 22)
7In Indian Network for People living with HIV/AIDS v Union of India (2008), the Madras High Court held that “Rule 55(6) of the said Rules, which is confined only to a pre-grant stage clearly characterize the pre-grant exercise by the Controller as proceedings” and that “Thus, the pre-grant opposition proceedings come within the sweep of any proceedings under Section 77 of the said Act.” (para 23) It held that “The Controller, before whom the proceedings takes place, is endowed with some of the powers of a Civil Court, and whose order or costs are executable as a decree of a Civil Court, is thus having the trappings of a Civil Court. Proceeding before such an authority are obviously a quasi-judicial proceedings. In a pre-grant stage, the Controller is also deciding a controversy, which is raised by the objector opposing the grant of patent and the applicant who applies for the grant.” (para 24) Applying the test of Kihoto Hollohan v Zachillhu 1992 Supp (2) SCC 651, it held that “this Court holds that the third respondent functions as a quasi-judicial tribunal and has to decide the lis” (para 28).
8In Glochem Industries v Cadila Healthcare (2009), to which Neon refers (Neon paras 42-43), a Division Bench of the Bombay High Court held that “the authority is obliged to consider the representation by way of pre-grant opposition under Section 25(1) keeping in mind the parameters of law by observing principles of natural justice” (para 7), and that “There is no difficulty in accepting the argument of the Respondent No. 1 that the enquiry contemplated at the stage of pre-grant opposition is a summary enquiry. Nevertheless, the principles of natural justice will have to be adhered to even during that enquiry. Moreover, keeping in mind the plain language of Section 79 of the Act, its application is not limited to enquiry under Section 25(2) of the Act. On the other hand, Section 79 postulates that the requirement specified under that Section is applicable in respect of ‘any proceeding’ under the Act before the controller. That expression would certainly take within its fold enquiry under Section 25(1) of the Act.” (para 9) The Bench did not decide whether the two remedies differ in kind, “It is not necessary for us to examine the argument of the Petitioners that the remedy of pre-grant opposition is qualitatively different than the remedy of post-grant opposition.” (para 7)
9Though an applicant can appeal from the order of the Controller in pre-grant opposition proceedings to the High Court, there is no provision under which an opponent can make such an appeal." (See the TRIPS Agreement, art 64.5 which states that the members shall be under no obligation to provide an opportunity for review of decisions in cases of unsuccessful opposition or administrative revocation, if the grounds for such procedures can be the subject of invalidation procedures.) Where, pursuant to pre-grant opposition the Controller grants a patent, the opponent will have no right of appeal to the High Court. It is submitted that the filing of a writ petition against the order of grant of patent, rejecting the opposition, will not be appropriate as the Act provides for a scheme to challenge patents. The remedy will be either to initiate post-grant opposition proceedings before the Controller or file a petition for revocation before the High Court. The absence of appellate remedy further emphasises the fact that the opponent is not a party to the pre-grant opposition proceedings. (See the TRIPS Agreement, art 41.4, which grants the opportunity of judicial review of final administrative decisions only to ‘parties to a proceeding’.) There is no specific provision similar to r 63 of the Patents by which an opponent can be eligible for costs of opposition, though the Controller has a general power to order costs in proceedings before him. (See the Patents Act 1970, s 77(2) and the Patents Rules 2003, r 136.)
10In Novartis v Natco Pharma (2024) a Division Bench of the Delhi High Court held that “the representation by way of opposition under Section 25(1) has been rightly described as being in aid of the power of examination that is exercised by the Controller” (para 82), that “it would be incorrect to characterise the proceedings at that stage to be adversarial” and that “it would be incorrect to view those proceedings as representing a lis as that phrase is legally understood” (para 83), and that “the opponent can claim a right of hearing only if the Controller is satisfied and is of the opinion that the representation merits consideration. A mere filing of a representation would not prompt or precipitate issuance of notice under Rule 55(4).” (para 95) Of the Bombay decision it observed that “the decisions in Neon Laboratories as well as Best Agrolife related to voluntary amendments introduced by the patent applicant” (para 122). Following that decision, the Court held in Fresenius Kabi Ipsum Srl v Asst. Controller of Patents and Designs (2026) that “the upshot of the decision of the Division Bench is that Sections 14 and 25(1) are two distinct statutory pathways and do not merge and any theory of convergence must be rejected. This simply means that a hearing granted to an applicant seeking grant of patent under Section 25(1) operates in a different field and cannot be a reason enough to take away the opportunity of hearing envisaged separately under Section 14 of 1970 Act.” (para 47)
Supreme Court of India·21 August 2008
High Court of Bombay·6 November 2009
High Court of Delhi·31 August 2026
How does pre-grant opposition to a patent application work in India?
Can an unsuccessful opponent appeal the Controller's order in an opposition?
Doctrine page · Written by Prof. Feroz Ali
www.aop.onl/pre-grant-nature